News about Global Pharma

MTPA Presents Healthcare Resource Utilization Data in RADICAVA ORS at AMCP 2024

Mitsubishi Tanabe Pharma America, Inc. (MTPA) has recently presented one abstract on amyotrophic lateral sclerosis (ALS) at the Academy of Managed Care Pharmacy (AMCP) 2024 Annual Meeting.

Global Pharma | 16/04/2024 | By Aishwarya |  555

Neurvati Neurosciences Apoints Deborah Dunsire, MD, as Member and Chair of Company Board of Directors

Neurvati Neurosciences announced the appointment of Dr. Deborah Dunsire as a new member and the new chair of the company's board of directors.

Global Pharma | 15/04/2024 | By Manvi |  832

Viatris Appoints Corinne Le Goff as Chief Commercial Officer

Viatris Inc. announced that Corinne Le Goff has joined the company as Chief Commercial Officer and will become a member of the company's Executive Leadership Team.

Global Pharma | 15/04/2024 | By Manvi |  423

Kiora Receives Grant from CRF for Clinical Trial Endpoints for Inherited Retinal Diseases

Kiora Pharmaceuticals has secured grant funding from the Choroideremia Research Foundation (CRF) in support of validating functional vision assessments for patients with profound blindness.

Global Pharma | 15/04/2024 | By Aishwarya |  329

Granules India Unit V Facility Completes US FDA Inspection with Zero 483 Observations

Granules India Ltd. has announced that the company’s Unit V facility has completed the US Food and Drug Administration (FDA) inspection between April 8-12, 2024, resulting in zero 483 observations.

Global Pharma | 15/04/2024 | By Aishwarya |  1155

FDA Approves New Administration Options for XCOPRI to Address Needs of Patients with Seizures

The newly approved administration options allow XCOPRI tablets to be crushed and mixed with water, providing patients with additional flexibility in medication administration.

Global Pharma | 15/04/2024 | By Abha |  514

Asahi Kasei Bioprocess and Axolabs Forge Alliance to Propel Oligonucleotide Therapeutics

Oligonucleotide therapies offer a targeted approach to treating diseases by modulating gene expression, splicing, and protein production.

Global Pharma | 15/04/2024 | By Abha |  900

Awshad Rolls Out Brain-Boosting Nutritional Supplement Myndshroom

Awshad, a pioneering medical cannabis wellness startup, has rolled out its latest innovation, Myndshroom.

Global Pharma | 15/04/2024 | By Aishwarya |  1141

Thermo Fisher Introduces CTS OpTmizer One SFM to Boost Cell Therapy Manufacturing

Thermo Fisher Scientific has introduced the Gibco CTS OpTmizer One Serum-Free Medium (CTS OpTmizer One SFM).

Global Pharma | 15/04/2024 | By Aishwarya |  813

AbbVie Announces Late-Breaking Data at AAN Supporting Long-Term Safety and Efficacy of Atogepant for Preventive Treatment of Migraine

The overall long-term safety results were consistent with the known safety profile of atogepant in chronic and episodic migraine, and no new safety signals were identified.

Global Pharma | 12/04/2024 | By Manvi |  670